REFERENCES

1. 1.↵
   1. Freilinger TM,
   2. Schindler A,
   3. Schmidt C,
   4. et al

   . Prevalence of nonstenosing, complicated atherosclerotic plaques in cryptogenic stroke. JACC Cardiovasc Imaging 2012;5:397–405

   CrossRefPubMed
2. 2.↵
   1. Lindsay AC,
   2. Biasiolli L,
   3. Lee JM,
   4. et al

   . Plaque features associated with increased cerebral infarction after minor stroke and TIA: a prospective, case-control, 3-T carotid artery MR imaging study. JACC Cardiovasc Imaging 2012;5:388–96

   CrossRefPubMed
3. 3.↵
   1. Bezerra HG,
   2. Costa MA,
   3. Guagliumi G,
   4. et al

   . Intracoronary optical coherence tomography: a comprehensive review clinical and research applications. JACC Cardiovasc Interv 2009;2:1035–46

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Kume T,
   2. Akasaka T,
   3. Kawamoto T,
   4. et al

   . Assessment of coronary arterial plaque by optical coherence tomography. Am J Cardiol 2006;97:1172–75

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Kume T,
   2. Okura H,
   3. Kawamoto T,
   4. et al

   . Assessment of the coronary calcification by optical coherence tomography. EuroIntervention 2011;6:768–72

   CrossRefPubMed
6. 6.↵
   1. Kubo T,
   2. Imanishi T,
   3. Takarada S,
   4. et al

   . Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol 2007;50:933–39

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Yabushita H,
   2. Bouma BE,
   3. Houser SL,
   4. et al

   . Characterization of human atherosclerosis by optical coherence tomography. Circulation 2002;106:1640–45

   Abstract/FREE Full Text
8. 8.↵
   1. Stamper D,
   2. Weissman NJ,
   3. Brezinski M

   . Plaque characterization with optical coherence tomography. J Am Coll Cardiol 2006;47:C69–79

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Bezerra HG,
   2. Attizzani GF,
   3. Costa MA

   . Three-dimensional imaging of fibrous cap by frequency-domain optical coherence tomography. Catheter Cardiovasc Interv 2011 Sep 27 [Epub ahead of print].
10. 10.↵
    1. Jones MR,
    2. Attizzani GF,
    3. Given CA 2nd.,
    4. et al

    . Intravascular frequency-domain optical coherence tomography assessment of atherosclerosis and stent-vessel interactions in human carotid arteries. AJNR Am J Neuroradiol 2012;33:1494–501

    Abstract/FREE Full Text
11. 11.↵
    1. Yoshimura S,
    2. Kawasaki M,
    3. Yamada K,
    4. et al

    . Visualization of internal carotid artery atherosclerotic plaques in symptomatic and asymptomatic patients: a comparison of optical coherence tomography and intravascular ultrsound. AJNR Am J Neuroradiol 2012;33:308–13

    Abstract/FREE Full Text
12. 12.↵
    1. Yoshimura S,
    2. Kawasaki M,
    3. Hattori A,
    4. et al

    . Demonstration of intraluminal thrombus in the carotid artery by optical coherence tomography: technical case report. Neurosurgery 2010 Sep;67(3 Suppl Operative):onsE305; discussion onsE305

    CrossRefPubMed
13. 13.↵
    1. Reimers B,
    2. Nikas D,
    3. Stabile E,
    4. et al

    . Preliminary experience with optical coherence tomography imaging to evaluate carotid artery stents: safety, feasibility and techniques. EuroIntervention 2011;7:98–105

    CrossRefPubMed
14. 14.↵
    1. Yoshimura S,
    2. Kawasaki M,
    3. Yamada K,
    4. et al

    . OCT of human carotid arterial plaques. JACC Cardiovasc Imaging 2011;4:432–36

    CrossRefPubMed
15. 15.↵
    1. Setacci C,
    2. de Donato G,
    3. Setacci F,
    4. et al

    . Safety and feasibility of intravascular optical coherence tomography using a nonocclusive technique to evaluate carotid plaques before and after stent deployment. J Endovasc Ther 2012;19:303–11

    Abstract/FREE Full Text
16. 16.↵
    1. Takarada S,
    2. Imanishi T,
    3. Liu Y,
    4. et al

    . Advantage of next-generation frequency-domain optical coherence tomography compared with conventional time-domain system in the assessment of coronary lesion. Catheter Cardiovasc Interv 2010;75:202–06

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Guagliumi G,
    2. Bezerra HG,
    3. Sirbu V,
    4. et al

    . Serial assessment of coronary artery response to paclitaxel-eluting stents using optical coherence tomography. Circ Cardiovasc Interv 2012;5:30–38

    Abstract/FREE Full Text
18. 18.↵
    1. Guagliumi G,
    2. Ikejima I,
    3. Sirbu V,
    4. et al

    . Impact of drug release kinetics on vascular response to different zotarolimus-eluting stents implanted in patients with long coronary stenoses: the LongOCT study (Optical Coherence Tomography in Long Lesions). J Am Coll Cardiol Intv 2011;4:778–85

    CrossRef
19. 19.↵
    1. Li X,
    2. Villard JW,
    3. Ouyang Y,
    4. et al

    . Safety and efficacy of frequency domain optical coherence tomography in pigs. EuroIntervention 2011;7:497–504

    CrossRefPubMed
20. 20.↵
    1. Yousem DM,
    2. Trinh BC

    . Injection rates for neuroangiography: results of a survey. AJNR Am J Neuroradiol 2001;22:1838–40

    Abstract/FREE Full Text
21. 21.↵
    1. Morris PP

    , ed. Performing a cerebral or spinal arteriogram. In: Practical Neuroangiography. Baltimore: Lippincott Williams & Wilkins;1997:48
22. 22.↵
    1. Ozaki Y,
    2. Kitabata H,
    3. Tsujioka H,
    4. et al

    . Comparison of contrast media and low-molecular-weight dextran for frequency-domain optical coherence tomography. Circ J 2012;76:922–27

    CrossRefPubMed
23. 23.↵
    1. Brezinski M,
    2. Saunders K,
    3. Jesser C,
    4. et al

    . Index matching to improve optical coherence tomography imaging through blood. Circulation 2001;103:1999–2003

    Abstract/FREE Full Text
24. 24.↵
    1. Data JL,
    2. Nies AS

    . Drugs five years later: dextran 40. Ann Intern Med 1974;81:500–04

    CrossRefPubMed
25. 25.↵
    1. Seeliger E,
    2. Flemming B,
    3. Wronski T,
    4. et al

    . Viscosity of contrast media perturbs renal hemodynamics. J Am Soc Nephrol 2007;18:2912–20

    Abstract/FREE Full Text